I. (Feature selection): The need to identify clinically relevant disease subtypes and driving molecular signatures which can be targeted for treatment |
Performing both sample clustering and feature selection |
iCluster; iClusterPlus; iClusterBayes; intNMF; IS-K means; CIMLR; PSDF |
II. (Mixed-type data): Large scale genomic data of mixed-type in large consortia |
Integrating mixed type of data |
iClusterPlus; iClusterBayes; moCluster; LRAcluster; MDI; SNF; CIMLR; rMKL-LPP; PINS; PINSPlus |
III. (Computational efficiency): Concern on the computational resources and consumption of time |
Computationally efficient |
Spectrum; SNF; ab-SNF; NEMO; CIMLR; rMKL-LPP |
IV. (Knowledge integration): Leveraging the prior knowledge |
Incorporating prior information |
IS-K means; PARADIGM |